About Purigen biosystems
Purigen Biosystems: Revolutionizing DNA and RNA Extraction for Cancer Research
Purigen Biosystems is a leading biotechnology company that specializes in automated extraction, isolation, and purification of DNA and RNA from FFPE (formalin-fixed paraffin-embedded) tissues and cells. The company's innovative isotachophoresis charge-based extraction technology has revolutionized the field of cancer research by enabling faster, more accurate, and more efficient analysis of genetic material.
At Purigen Biosystems, we understand the critical role that DNA and RNA play in cancer diagnosis, treatment, and prevention. Our mission is to empower researchers with cutting-edge tools that enable them to unlock the full potential of genomic data. By providing high-quality nucleic acid samples that are free from contaminants or degradation, we help our customers accelerate their research projects while minimizing errors or false positives.
Our proprietary isotachophoresis technology uses an electric field to separate charged molecules based on their size-to-charge ratio. This approach allows us to selectively extract nucleic acids from complex biological matrices such as FFPE tissues or blood samples without the need for organic solvents or harsh chemicals. As a result, our method yields higher quality DNA/RNA with better purity than traditional methods.
One key advantage of our technology is its ability to handle small sample sizes (down to 10 ng). This feature is particularly important in oncology research where precious tissue specimens are often limited. With Purigen Biosystems' automated platform (the Ionic® System), researchers can process up to 96 samples simultaneously with minimal hands-on time required. The system integrates seamlessly into existing workflows and can be customized for specific applications such as targeted sequencing or gene expression profiling.
Another benefit of our technology is its compatibility with downstream applications such as PCR (polymerase chain reaction), NGS (next-generation sequencing), microarrays, or digital droplet PCR. By providing high-quality input material for these assays, we help researchers obtain more reliable and reproducible results. Our technology also reduces the risk of false positives or negatives due to sample degradation or contamination.
Purigen Biosystems' products and services are used by leading academic institutions, pharmaceutical companies, and clinical laboratories worldwide. Our customers appreciate the ease of use, reliability, and cost-effectiveness of our solutions. They also value our commitment to quality control and customer support. We work closely with our clients to understand their needs and provide customized solutions that meet their specific requirements.
In summary, Purigen Biosystems is a game-changer in the field of DNA/RNA extraction for cancer research. Our isotachophoresis technology offers numerous advantages over traditional methods such as higher yield, better purity, smaller sample size requirement, compatibility with downstream applications, automation capability, and cost-effectiveness. We are proud to contribute to the advancement of science by providing innovative tools that enable researchers to make breakthrough discoveries in oncology research.